Skip to main content

Language: English / Gàidhlig

Loading…
Chamber and committees

Finance Committee, 07 Oct 2003

Meeting date: Tuesday, October 7, 2003


Contents


National Health Service Reform (Scotland) Bill: Financial Memorandum

The Convener (Des McNulty):

I welcome people to the ninth meeting of the Finance Committee in the second session of the Parliament. I welcome the press and the public and remind members and anyone else that pagers and mobile phones should be switched off. We have received apologies from Ted Brocklebank, but I think that everyone else is present.

The first item on the agenda is further consideration of the National Health Service Reform (Scotland) Bill. I welcome witnesses from the Scottish Executive Health Department: Lorna Clark, the bill team manager; Dr Hamish Wilson, head of the primary care division; and Alistair Brown, head of the performance management division.

Members have a copy of various written submissions, including one from the Scottish Association of Health Councils, which gave evidence to the committee last week. We also received a submission from the Scottish Executive yesterday by e-mail—a paper copy of that submission is available to members.

I invite the Executive witnesses to make a brief opening statement.

Lorna Clark (Scottish Executive Health Department):

As we know that time is limited this morning, we thought that it would be helpful if we made a brief statement and responded to some of the main points that have been raised by those who have provided written evidence on the bill and those who gave oral evidence to the committee last week.

I will start by setting the matter in context. This year, the Scottish Executive will spend £7.2 billion on health, most of which is allocated to the 15 health boards to manage and deliver health care services in their areas. That represents a rise of £1 billion since 2001-02 and the amount that we spend on health will increase still further to £8.5 billion by 2005-06. In the light of those resources, the Scottish Executive stands by the statement in the financial memorandum that there will be no additional expenditure associated with the bill.

We are aware that some witnesses have argued that there will be start-up costs associated with the establishment of community health partnerships. Funding is already provided for the management of a larger number of local health care co-operatives and some of that funding will be used to assist with the evolutionary development of CHPs. In addition, money is available through the change and innovation fund to assist with service redesign. We believe that health boards already have the capacity to manage the evolutionary change from LHCCs to CHPs within their existing management resources. That is supported by NHS Ayrshire and Arran, which said in its submission that what is required is a redistribution of resources and that there should be no overall cost increase.

On the powers of intervention, the financial memorandum states that the costs will depend on how the powers are used. We note from the evidence that the committee received last week that Argyll and Clyde NHS Board's experience of intervention cost about £300,000. We do not dispute that figure but we point out that that was a significant intervention that related to the departure of four staff at chief executive level. We suggest that any use of the intervention power following the bill is likely to be more targeted and therefore less expensive than was the case with NHS Argyll and Clyde. Of course, much depends on individual circumstances and it is difficult to indicate what an average intervention might cost, because each intervention is different and is costed according to the way in which it is run.

In practice, public involvement is already a core function of the national health service and, as such, is funded through the general financial allocation for the provision of health services. It is not a new or additional function; the bill simply makes the practice a statutory duty. The department is putting more money into public involvement nationally. Our patient focus and public involvement programme is investing some £4 million a year into national work to help the NHS, the voluntary sector, patients and the public to work together as equal partners and, by doing so, to improve the quality of the public consultation that is undertaken by the NHS. It is anticipated that the proposed Scottish health council will take over some of that responsibility and some of the central funding that supports that work.

The functions of the Scottish health council and its local advisory councils will be different from those of today's local health councils. Although it is true that the Scottish health council will have some functions that were not previously carried out by local health councils, it will not do many of the things that are currently undertaken by local health councils. The Executive's view is that, on balance, the existing allocation to local health councils will be sufficient to set up and run the Scottish health council.

That was a brief summary and I look forward to discussing the issues further with the committee.

The Convener:

Thank you for your statement and for giving us a copy in writing. By and large, the processes that are needed to abolish the trusts do not need legislation. What is required of the bill is a legislative tidy-up. However, there is an issue about the costs that are associated with the abolition of the trusts. Would it not be better to give us an outline balance sheet to show how the savings might be arrived at and how any additional costs might be met, rather than to assume that they will somehow be netted out of the process, which seems to be the substance of your comments?

Alistair Brown (Scottish Executive Health Department):

The work that we have done and our discussions with the NHS suggest that the direct cost of abolishing trusts is very low and is entirely administrative. As you suggested, the abolition of trusts is already going ahead under the legislative provisions of the National Health Service (Scotland) Act 1978. It is clear to us from our conversations with those in the NHS that, as I said, the costs will be very low. Other witnesses have suggested to the committee that opportunities for savings will be presented through single-system working and, for example, developing joint human resources and finance functions that cover the former trusts and boards in a single area. We expect savings from that, but we expect board areas to redeploy those savings towards improving patient care.

The Convener:

Would it not have been better to give us a true financial assessment of savings that can be clearly identified and of any additional costs, especially in the initial phases, rather than to assume that the overall effect on costs will be netted out?

Alistair Brown:

Producing such a statement would be difficult for the Health Department because it would need to be accurate for each health board. In time, individual health boards may be able to describe costs that they have incurred and savings that they have realised, but we expect those figures to be small in comparison with the overall sums of money that are being discussed.

My question relates to scrutiny and our function is to scrutinise. I might want to accept your assurances, but I have the reasonable expectation that you can provide some figures.

Alistair Brown:

We cannot give the committee figures today. Dissolutions are already beginning so I repeat with confidence that the costs that are associated with dissolutions are not material. I will not say that they do not exist, because some staff must be deployed to draw up consultation measures and undertake consultation, but the costs are very small. We cannot yet indicate possible savings from single-system working, but we are beginning to observe its results in the Borders and in Dumfries and Galloway, where trusts were formally dissolved on 1 April this year.

Fergus Ewing (Inverness East, Nairn and Lochaber) (SNP):

It is obviously the duty of ministers to provide a clear financial memorandum, which means providing a clear estimate of how much a bill will cost. Paragraph 42 of the financial memorandum says:

"There will be no additional expenditure".

However, you just said that you cannot produce figures because they would need to be accurate and you do not know how much each health board's proposals will cost. How did you conclude that no costs would be incurred, given proposed new section 4A(5) of the 1978 act, which entitles ministers to produce regulations that stipulate the number of CHPs, the number of staff and how CHPs operate? How many CHPs will be created and how much will they cost in total?

Alistair Brown:

Your last point took me from the costs and savings that are associated with the dissolution of trusts to community health partnerships. One of my colleagues will have to comment on the partnerships.

Your first point was about whether we really know the costs that are associated with the bill and in particular with section 1, which is on the dissolution of trusts. We stand absolutely by the financial memorandum's statement that no costs of any significance will be associated with dissolving trusts.

Dr Hamish Wilson (Scottish Executive Health Department):

I will bring the committee up to date on community health partnerships. As was requested in the white paper "Partnership for Care", each area is considering its current configuration of local health care co-operatives and what that might mean for community health partnerships. That exercise has not concluded, so although some areas have a fairly clear idea of the appropriate number of community health partnerships to deliver what the white paper requires, others have not reached that stage. However, the information that we have suggests that we are heading for about 50 partnerships. I stress that that figure is provisional and is based on the best information that is available. There are roughly 80 local health care co-operatives in Scotland, so the number of bodies will change.

Fergus Ewing:

We discovered this morning that one of the few times that ministers made any attempt to predict in the financial memorandum how much the bill would cost relates to the powers of intervention, whose use is expected to cost about £85,000. However, the witnesses today appeared to accept the figure of £300,000, so that error is of a factor of nearly 400 per cent.

The almost total lack of figures in the financial memorandum contrasts markedly with the approach that ministers took in the financial memorandum for the Vulnerable Witnesses (Scotland) Bill, which contains a clear list of figures and costed measures. Dr Wilson admitted that the Executive does not know how many CHPs will be created so, by definition, we do not know how much the bill will cost. The financial memorandum contains about as much hard fact as the average astrological chart does. The prediction might well have been made by Mystic Meg. That is simply not good enough.

Such a bill should not be introduced until the Minister for Finance and Public Services and his deputy can tell the Parliament how much it will cost. If the Executive cannot do that—the witnesses have admitted that they cannot—a clear balance sheet should be produced that shows ranges of estimates and of costs, as the convener said. Without that, we are being asked to sign a blank cheque and we do not know whether that is a Scottish Natural Heritage relocation cheque of £30 million or a Holyrood cheque of £400 million. Are not the financial memorandum and the lack of detail in the witnesses' responses, which I presume that ministers support, unacceptable?

I am not sure whether that was a political speech or a request for factual evidence, but I will allow the witnesses to respond on factual issues.

Alistair Brown:

I will respond in a way that I hope is helpful on the costs of the powers of intervention. Mr Ewing is right to draw attention to the fact that the financial memorandum contains the figure of £85,000. The memorandum explains that that would be the cost of a task force that comprised six people and lasted 10 months.

In the Executive's opening statement, we said that we would not disagree with the figure of £300,000 that Neil Campbell of NHS Argyll and Clyde submitted to the committee. Both figures are correct, because they represent different interventions at different times. The figure of £85,000 is taken from a parliamentary answer of December 2000. The question related to a task force that ministers asked to go into Tayside NHS Board in February that year and which completed its work in autumn 2000. According to the parliamentary answer, the cost of that task force was £84,467. That is where our figure of £85,000 came from, so I assure the committee that it has a factual basis.

Ms Wendy Alexander (Paisley North) (Lab):

I will pursue that point. The figure might have a factual basis, but that is not the issue that the financial memorandum deals with. The memorandum concerns estimated costs for the forthcoming four years. We all appreciate the difficulties of costing prospective interventions, but at least four examples can be found in the past of interventions that the Parliament would have sought if the new powers had been available.

In the Parliament's first year, the Ruddle inquiry was held and issues that were specific to Carstairs were considered. Those matters would be unlikely to fall under the bill's provisions, but that was an area-specific intervention. The Tayside intervention, which Alistair Brown mentioned, then took place. The important issue is not the cost of that intervention as it was carried out but what might be the cost given the powers of intervention that are laid out in the bill and where those costs would fall. The question is whether the cost would fall to the Executive or the health boards.

In the third year, we had the example of the Beatson in Glasgow. Because of the legislative power that we are about to create for ministers, there will probably be some central intervention in future in such cases. No doubt Greater Glasgow NHS Board would be able to provide some indication of the costs. Most recently, we had the example of NHS Argyll and Clyde. Again, the powers in the bill make it likely that costs will accrue to the Executive.

We have had one intervention a year and more interventions are now likely because of the wider scope of the bill. It would be helpful if officials could write to us about the costs of the interventions in Tayside, the Beatson and Argyll and Clyde. It is a little surprising that those interventions were not considered when the financial memorandum was drawn up, but these things happen. The costs of those interventions could be agreed with the three health boards involved and used as a benchmark.

It is arguable that the sums of money involved are trivial when compared with a £7 billion budget. Had the financial memorandum said that the costs would be residual in such a budget, that would be fine. However, the artificial precision of £85,000 creates a danger. I do not think that that figure bears any relation to what the Tayside, Beatson or Argyll and Clyde interventions would have cost under the powers that we are creating.

Will you comment in more detail on the Argyll and Clyde case? I am disturbed by the justification in your paper, which says that the intervention was very significant and related to the departure of four staff at chief executive level. It seems to me that we should be costing not the outcome but the input. The input was a relatively small number of people who went in for a relatively short time. In the intervention team of four members, one was a senior local government official and one was from the private sector. On average, those people would be on a salary of, say, £100,000. The team spent six months looking into systemic mismanagement in a health board with a budget of hundreds of millions of pounds. Six months is a short time but the salaries of the four people would come to £200,000—let alone any backfill associated with their previous employment.

Do you envisage having intervention teams of fewer than four people, for periods of less than six months? That does not seem commensurate with the provisions in the bill or the likelihood—given past experience—of where interventions will have to take place. The outcome is not really the issue; the issue is the input required to intervene in the management of a health board.

I think that there were several questions there.

Alistair Brown:

Ms Alexander asked that we write to the committee about the costs of the interventions that she listed. We would, of course, be happy to do that as soon as we can.

That would be welcome.

Alistair Brown:

It may take us a little while to look back at papers that are now up to three or four years old.

I make one general point about the proposed new power of intervention in the bill. The policy intention is clearly that it should be used as a power of last resort. The words "last resort" appear not in the white paper but in the Executive's partnership agreement. We believe that that policy intention is carried into the wording of the bill, through the necessity test. In section 4 of the bill, proposed new section 78A(2) of the 1978 act states that

"The Scottish Ministers may, where they consider it necessary for the purpose of ensuring the provision of the service",

direct certain things. The lawyers advise us that that carries into the bill the policy intention that intervention should be a last resort—when other means of turning round poor or failing performance have been tried and failed, or when ministers judge that there is no reasonable prospect of such means succeeding.

I make that point to set Ms Alexander's comments in context. One cannot assume that, had the proposed new powers been in effect back in 1999, ministers would have decided to use them in the Ruddle, Tayside, Beatson and Argyll and Clyde cases. The intervention in each of those four cases was based on agreement between the Scottish Executive Health Department and the health body concerned.

That observation may not be relevant to the cost of an intervention, once a decision to intervene has been taken, but it may help the committee to judge how frequently ministers expect the intervention powers to be used. The answer is that they will not be used frequently. They will be used as a last resort only after a range of other interventions and actions has been attempted.

I accept Ms Alexander's comment about the artificial precision of the £85,000. We were trying to be helpful and I have made it clear where that number came from. It may help the committee if I explain why that figure seems small. The Tayside task force had a number of members and was in Tayside for nine or 10 months. At least one of the members was a recently retired senior chief executive in the health service. The cost of deploying him in Tayside was, in fact, remarkably low. I cannot give the committee the figures right now, but the additional cost to the public was very low. Other members of the Tayside task force had other jobs and were deployed for only one or two days a week.

Dr Elaine Murray (Dumfries) (Lab):

Wendy Alexander raised a number of the points that concerned me. You have just suggested that the Tayside example may have been an exception because you had available to you a recently retired chief executive whose cost was relatively low. That would not be the case in every intervention. We have been considering Tayside and Argyll and Clyde but it is difficult to say which is the exception and which is the rule. It could be that Argyll and Clyde is more typical than Tayside. My genuine concern about the level of costs remains and, in its submission to the committee, the British Medical Association expressed a similar concern.

The financial memorandum seems to say that the cost burden would fall on the health board rather than on the Scottish Executive. Can you explain that to me? It would be surely be easier for the Executive to absorb the cost of an intervention than it would be for the health board, which might be in significant financial difficulties at the time of the intervention. Even £300,000 is a small sum when compared with the Health Department's budget or with the end-year flexibility figures that we have been discussing recently.

Alistair Brown:

We have been giving thought to the very question that Dr Murray raises. The question of who would bear any additional cost of such an intervention would be for discussion between ministers and the department on one hand and the health board in difficulty on the other. The conclusion reached would depend on the circumstances. The financial memorandum certainly states that costs would be

"contained within existing NHS financial allocations."

That would be our starting point. If an NHS board argued that the costs would damage service provision, for example, ministers would listen very carefully to that argument.

Has that discussion taken place in the specific context of NHS Argyll and Clyde?

Alistair Brown:

I cannot provide a factual answer to that question now. I will have to write to the committee with the information.

John Swinburne (Central Scotland) (SSCUP):

The public regard this exercise as rather meaningless. They believe that the structure of the NHS is top heavy. There are not enough people at the sharp end—the delivery end—doing the good work that nurses, surgeons, doctors and so on do, and there are too many systems analysts and people counting the number of patients who are bedblocking. Although the bill will not save any money, will it make the system more efficient?

Lorna Clark:

We have figures for management costs in the NHS, which show them to be quite small.

Dr Wilson:

For a number of years, management costs in the NHS have run at around 5 per cent of total revenue. As the financial memorandum makes clear, it is expected that that figure will not be exceeded as a result of the measures that are being taken and that management costs will be contained at 5 per cent of total revenue.

As Alistair Brown mentioned, the abolition of trusts and the reunification of NHS boards offer us an opportunity to make savings by ensuring that support services are provided in a more efficient manner than they have been in recent years. Alistair Brown gave some examples of that. One of the fundamental aims of the white paper and the partnership agreement is to ensure that clinicians in the front line are empowered to get on with delivering the services that they believe local communities need. The white paper makes it clear that one reason for creating community health partnerships, which have evolved from local health care co-operatives, is to continue enabling clinicians in the front line to feel that they are in the driving seat when delivering care with the resources that they require to respond to local communities' needs.

Kate Maclean (Dundee West) (Lab):

Like other members, I am concerned about the lack of financial clarity surrounding the bill. In response to Fergus Ewing's question about the cost of intervention, Alastair Brown cited the cost of the Tayside task force as an example. However, in response to Wendy Alexander's question he referred to various factors that kept the costs so low in Tayside. That leads one to believe that the figure that the financial memorandum provides for the cost of using the powers of intervention is inadequate.

Can you say more about the costs of dissolving trusts? In response to a number of questions, you said that those costs would be minimal. My experience is that with any kind of reorganisation there are often initial, non-recurring costs, which lead to savings a year or two down the road. If there are to be reforms and trusts are to be dissolved, leading to savings further down the road, it is difficult to believe that there will not be initial, non-recurring costs. I am concerned that we are being asked to agree to something with no idea of what costs and potential savings will be.

Alistair Brown:

Kate Maclean suggests that the £85,000 is inadequate. The financial memorandum makes it clear that costs would be incurred only if the new powers were used and that the amount spent would depend on how the powers were used. That is an obvious statement, but it is worth my putting it on the record.

The cost estimate that I gave for the Tayside task force was the department's final reckoning at the end of 2000; I regard it as accurate. We should not lose sight of the fact that powers of intervention may be used in future to pinpoint a particular service that has gone wrong. In those circumstances intervention would be limited and sharply targeted, so it might cost only £10,000 or £20,000.

Neil Campbell gave the committee the example of the intervention that took place in Argyll and Clyde NHS Board. I accept fully that, because of the nature of the difficulties there, that intervention has had to be quite wide ranging and costs have been higher.

Kate Maclean's second question was about the costs of dissolution of trusts and the savings that might arise from that. The most helpful thing that I can do is to point to the experience of Borders NHS Board and Dumfries and Galloway NHS Board, where trusts were dissolved with effect from 1 April. I have had conversations with the chief executives in both of those NHS systems on the abolition of trusts and in neither case were costs an issue. Both chief executives are working to rationalise administrative support in the NHS in their areas, especially in finance, human resources and information technology. Any savings that can be made will be available for the boards to invest in patient care, if they so choose. I hope that that answer is helpful.

If the savings are in personnel, are there no initial redundancy or early retirement costs?

Alistair Brown:

Since the publication in December 2000 of the white paper "Our National Health: A plan for action, a plan for change", which indicated that the policy direction was to move towards unified NHS systems, the NHS has been preparing for what we describe as single-system working. Although the final policy decision to wind up all the trusts was made explicit only in the white paper that was published in February this year, boards have been planning prudently for that. Many of them have appointed chief executives of trusts on an acting or interim basis, so that the question of redundancy does not arise.

Because of the natural rate of turnover of staff, at any point in time boards will have vacancies to fill. They have used that naturally occurring facility to ensure that the changes associated with moving to single-system working cost either nothing or very little in severance. I am not aware of any severance payments' having been paid in the two boards that have moved to dissolve trusts.

Dr Murray:

One reason why costs in Dumfries and Galloway NHS Board were not high was that a number of senior staff, including two chief executives of the board and the two trusts, had left and people were employed in those positions on an acting basis. It was relatively straightforward for people to be redeployed in the board. I do not know that we can be absolutely certain that it will be as easy for every board in Scotland to accommodate its personnel as it was for Dumfries and Galloway NHS Board.

Alistair Brown:

I accept Dr Murray's point. However, like Dumfries and Galloway NHS Board, other boards have been planning with single-system working in view and have made what preparations they can.

Jeremy Purvis (Tweeddale, Ettrick and Lauderdale) (LD):

I touch on the same issue in the context of Borders NHS Board, where there were previously three chief executives and where there is now one. In Borders NHS Board, redundancies and substantial costs were associated with the dissolution of trusts. Will a more co-ordinated approach to staffing reorganisation be taken throughout Scotland? When boards reorganise one by one, it is hard to relocate staff or to offer senior staff other opportunities in the NHS. Is it correct to say that if it were expected that the reorganisation would be carried out throughout Scotland, there would be more such opportunities for relocation and the burden of costs will not be that acute?

Alistair Brown:

A co-ordinated approach to relocating senior staff would reduce severance or other costs. Each NHS board is legally a separate employer and must fulfil its contract with its employees, including its senior staff. We must be careful not to interfere with that situation, because it is governed by employment law and the private contracts between the parties.

The NHS in Scotland is not so big that people are unaware of any vacancies that might arise or of senior staff who might be available to fill them. As a result, there is already an informal exchange of information of the kind that you suggest. As I said, the Health Department would have to be careful about intervening formally in that process, given the existing private and contractual relationships between the individuals concerned and their separate NHS employers.

Substantial management time was taken up and consultancy costs incurred in the reorganisation in the Borders. Am I right in saying that those costs were met by the Executive?

Alistair Brown:

Are you referring to consultancy costs?

Yes. I am referring in particular to management consultant costs.

Alistair Brown:

Do you mean in advising the NHS board on the move to single-system working?

Yes.

Alistair Brown:

As far as I am aware—and subject to checking—those costs were met by Borders NHS Board. However, if I find that I am wrong, I will write to the committee.

Jeremy Purvis:

Substantial management time will be taken up if each board wishes to move to single-system working. After all, a board might have to hire management consultants to advise it on such a major reorganisation. As a follow-up to Kate Maclean's question, are you confident that those costs will be met by efficiency savings that will result from single-system working? If so, have you received any indication from the boards that have reorganised about what they expect those greater efficiency savings to be?

Alistair Brown:

We have received a general indication from the boards that have reorganised and from those that are planning to do so that they expect to realise efficiency savings from bringing together functions that are currently being repeated in the health board and each of the trusts. However, that is not the driving force behind the policy of moving to single-system working. The policy intention remains to make care more patient-centred, and to make the transition between primary and secondary care more seamless. That is reflected in some of the written submissions that the committee has received, such as that from the British Medical Association's Scottish office.

Jeremy Purvis:

In the bill as drafted, there is a danger that, if a large board simply redesignates trusts into divisions, rebadges them, maintains the current management levels and in effect does not move towards single-system working, there would be increased costs without greater efficiency savings. Are you alive to that possibility?

Alistair Brown:

One has to draw a distinction between what might happen in the very short term and the opportunity that will thereafter open up for NHS systems to rationalise, for example, their support services. I certainly do not want to say to the committee that in some cases existing trusts will not be more or less substituted by new operating divisions after the trusts are dissolved. However, where that happens, I would not expect the NHS systems to stop there; I would expect that in time they would use such a step as a basis for further rationalisation. Although we are not pressing boards specifically to do that, we and many other stakeholders would encourage them to run their operations as efficiently as possible to ensure that as large a proportion as possible of their total income from the Health Department is devoted to patient care and front-line services.

Jim Mather (Highlands and Islands) (SNP):

I want to build on that comment. In any other setting and in most other areas of endeavour, we would expect any reform to have measurable returns on investment, which would be laid out and carefully measured from the start and come with a firm cost ceiling. Surely that must also be the case in an area of expenditure that amounts to a third of the Scottish budget. Do you envisage establishing reporting mechanisms to monitor performance and to encourage adequate performance along the lines that you described a moment ago in terms of there being more resources for front-line services, bureaucracy that will decrease over time, higher staff morale, reduced staff turnover, shorter waiting times, better outcomes, increased throughput and cost savings from streamlining and rationalisation? Such firm measures could be taken then segmented to provide an appropriate bill of materials and to ensure that performance can be monitored at individual levels.

Alistair Brown:

Mr Mather has provided a very full run-down of the aspects of NHS performance that we measure or that, in some cases—I want to make this clear to the committee—we would like to measure better than we do.

We should see the bill as the legislative implication of the policy that the Executive set out in "Partnership for Care: Scotland's Health white Paper", which was published at the end of February 2003. That white paper emphasises the importance of reform in the NHS to ensure that the additional resources that are being put in have maximum impact on the quality of patient care. We believe that the bill's measures are necessary to give legislative effect to that policy.

The performance of each NHS area is measured in a variety of ways and at different levels of detail. For the committee, perhaps the most useful gathering of those measures is in what is referred to as the performance assessment framework, which contains something like 90 quantitative measures of performance and other qualitative assessments. The framework certainly covers issues such as waiting times, patient experience, outcomes from surgery and so on. However, we would like to develop better measures of, for example, patient experience and similar softer issues for which it is not always possible to find a reliable numeric measure. The department continues to work on that with the NHS and others who advise us on such matters. As a result, I think that I can answer "Yes" to Mr Mather's question.

The Convener:

I want to move on to a slightly more technical issue. The primary care trusts that have already brought in LHCCs with extended involvement of the public and local authorities are probably not going to incur huge additional costs from the bill's proposed measures. However, I am concerned about less well-developed areas and locality structures in areas that will be overtaken by the new form of LHCCs. Given that the whole system depends on general practitioners' buying into it, are you concerned about moving from about 80 LHCCs to about 50 CHPs, and about sustaining locality structures where there is no correspondence between the existing LHCC and the proposed CHP? After all, such structures need to be sustained in some form.

Dr Wilson:

One of the fundamental aims is to build on the best of the LHCCs, as you have described. Each area has to strike a balance between representing, and being responsive to, a community and having the capacity to deliver the functions that the white paper, "Partnership for Care", outlines for community health partnerships.

On commitment from primary care contractors, one of the issues that we face is that we rely heavily on clinical involvement, not just from general practitioners but from other primary care professionals, to ensure that LHCCs are responsive. One of the major development areas that we expect boards to address in examining CHPs is clinical leadership. We will continue to work with local areas on that to ensure that community health partnerships are both responsive to the community and have the clinical leadership with buy-in from local clinical staff. We are trying to get the best from the LHCC model and work that into the new community health partnerships.

Given that LHCCs were voluntary initially, it is inevitable that there has been variable progress on them throughout Scotland. That is why it was felt that it was important to give community health partnerships a more formal place in the NHS so that they could be seen as an important part of what happens in the NHS locally and thereby gain credibility with the partners with which they work—local authorities are key to that.

All those factors put together seek to reinforce the principles behind "Partnership for Care", which is about communities, clinical buy-in and improving relationships with local authorities, the voluntary sector and so on.

The Convener:

The two core questions are whether the smaller locality structures will continue to be supported under the new model and whether funds are available to ensure that the needs of enlarged representation will be met. I am not sure what your answer was to either question.

Dr Wilson:

One has to consider each area to answer that question. We have already heard from a number of areas that wish to maintain within their community health partnerships' local identity—not necessarily a formal management structure, but something that maintains a locality's identity. That already exists within LHCCs. It is expected that there will be a shift of management effort from the LHCCs and other bits of the system, such as existing trusts or NHS boards, into community health partnerships. Equally, we will try to ensure that communication and other systems that exist are not lost in this new endeavour.

The Convener:

I move on to interventions and projected costs, on which we have had lengthy discussion. One thing that concerns me is the looseness of how the bill is drafted in relation to the possibility of interventions. It is clear that if there were a relatively limited number of major interventions, the costs could be contained by either the health board or NHS Scotland. What concerns me is that if NHS Quality Improvement Scotland finds many examples of inferior services, ministers could be obliged to intervene more than they have until now, for example in the four cases that Wendy Alexander mentioned. Would that have a substantial projected cost?

Alistair Brown:

The section of the bill that deals with powers of intervention grants a power to ministers rather than imposes a duty on them. The simple answer to your question is that ministers would use the power only where they felt it was justified and they chose to do so. It is relevant to repeat what I said earlier: the power of intervention is clearly intended to be used only as a last resort. The necessity test to which we refer conveys the policy intention through into the wording of the bill. I hope that that will help to reassure you. All the same, it is important that the power of intervention is available where it is necessary. We have therefore not constrained the power heavily in the drafting of the bill.

I want to go back to measurement. It is clear that 90 measures are too many for external reporting. What smaller number of measurements should the Parliament use to judge future performance?

Alistair Brown:

That is an interesting question. I will attempt briefly to justify why we have as many as 90 measures. We use the measures internally, although all 90 are reported publicly and are on the "Scottish health on the web" website. We use the measures to inform the discussions on performance that we have annually with NHS boards; it is important that we can look right across the range of their operations.

You asked which of the 90 measures and the qualitative assessments the Parliament and the Finance Committee would want to concentrate on. You have your own source of advice and expertise on such matters, so it is difficult for the Executive to give you a view on that. A lot depends on what is taking up the committee's attention at any given time. The indicators are designed deliberately to give a broad spectrum of measures. They relate to access, which is about how easy it is for people to receive health care and how long they have to wait for it; to quality, which is about how good the clinical outcomes are; to efficiency and to finance. Although there are not many indicators on the finance side, there are enough to enable us to monitor accurately how boards are performing. There are also indicators relating to patients' experience. We examine the incidence of health-care associated infection and boards' performance in relation to patient focus and public involvement. The committee would be able to choose from a broad spectrum of measures at any given time, depending on where its interests and investigations were leading it.

I believe that it would be helpful if there were three or four key indicators that all parties knew were being measured at the macro level and that would be reported on consistently on a long-term basis. Do you agree with that?

Alistair Brown:

Relative priorities and importance is a matter for ministers rather than for me. Mr Chisholm has recently agreed the 12 NHS priorities for 2004-05—the planning year that we are looking forward to—and they are the same 12 that he agreed for 2003-04.

I am anxious that we are drifting a wee bit from the bill.

Jeremy Purvis:

I have two quick questions on CHPs. We heard from the Scottish Association of Health Councils—this is supported by what Dr Wilson said this morning—that the nature of LHCCs' evolution from their initial voluntary basis meant that they received considerable funding in kind, which might not be available under a more structured system when they become CHPs. Do you share that view?

Dr Wilson:

I wonder whether there is confusion between LHCCs and local health councils. Perhaps the comment that you referred to was made in relation to local health councils rather than to local health care co-operatives. LHCCs receive funding directly from the NHS boards or primary care trusts.

Jeremy Purvis:

Is it anticipated that the new CHPs will incur more management costs because of the kind of work in which they may be involved. For example, their role in joint commissioning means that they will have a greater responsibility than their predecessors. Will not that increase the costs?

Dr Wilson:

The creation of community health partnerships will not, in itself, require additional management to support joint working between the health service and local authorities in social care, children's services and so on. The CHPs will give local authorities a specific focus at the individual community level. That is why there is a wish for greater coterminosity between community health partnerships and local authorities.

The whole joint future agenda is a practical example of joint commissioning that is already in place for NHS boards and local authorities. That effort would continue whether or not community health partnerships existed, although community health partnerships provide a clear focus for such activity in the NHS and there may be a practical advantage in their being coterminous with their local authorities. We do not see CHPs creating any additional financial pressures. The joint future agenda is a parallel agenda, which we wish to bring into the whole equation; it is not an extra.

The Convener:

There is an issue that I am still slightly unconvinced about. You are placing additional duties on CHPs with regard to public participation. I suspect that you will have to consider staffing issues and get more skilled staff into some positions, and other issues might arise in relation to liaison with local authorities that will incur other costs. The financial memorandum suggests that those additional costs can be met out of the existing funds for the LHCCs. Can you give us any further information about how you went about making that estimation?

Dr Wilson:

The financial memorandum makes reference to a reallocation of existing resources within each board, including the funding that is allocated to LHCCs; it does not refer only to the funding that currently supports LHCCs. As Alistair Brown said, as NHS trusts change and operating divisions or their successors come into place—and as NHS boards themselves change—they have the opportunity to enhance the support that is given to community health partnerships for specific functions that may be devolved from NHS boards or from what are currently NHS trusts. It is about not just the money that is used to support LHCCs, but the whole management infrastructure that exists in the NHS.

The Convener:

That gives rise to a further issue. The LHCC money is at least identified. Now you are talking about other money that might be reallocated, which you have not been able to quantify for us. You are saying that health boards might be able to contribute other money to the process of establishing the CHPs. To make your argument convincing, you must be able to say how much more than the LHCCs the CHPs will cost and how funding to meet that additional cost will be derived.

Dr Wilson:

Yes. That takes us back to our earlier discussion about the timing of events. At present, because local NHS board areas are considering how best they can configure their services for the future, it has not been possible for us to do what you have described.

The Convener:

I want to press you on another issue. One of the specific requirements of the bill is more systematic public consultation. Last week, we had some difficulty in getting from the health boards a sense of what that additional consultation would cost. Your assumption seems to be that health boards can meet the cost of the additional consultation from their current allocation. The same assumption is made in relation to the new Scottish health council being able to absorb the money that goes to the local health councils. It seems quite convenient that we can get more for less. Can you say more to convince us of that?

Lorna Clark:

Public involvement is not a new duty; it is something that NHS boards ensure routinely. The extent to which there is public involvement will depend on what sort of service change is being considered. For example, if a health board or a GP practice is considering a small change in how it operates, it will undertake a reasonably small consultation exercise on that. If a major service change is being considered, one would expect the consultation to incur a bit of a cost. Boards have been consulting in that way for years; it is not something new.

By introducing a statutory duty for public involvement, the bill recognises the increased priority that public involvement is being given. Some of the evidence that the committee took from NHS boards such as Ayrshire and Arran NHS Board reiterated our point that boards expect to have to involve the public. Involving the public in determining how services operate is a fundamental part of what the NHS does; the bill simply makes that statutory. We are not changing the way in which NHS boards go about their consultation; we are putting more money in from the centre to assist public consultation and to help to build capacity at a local level.

Boards are already involving the public in service redesign and consideration of how they can do things differently. The duty simply puts that on a statutory footing. We are not placing any additional responsibility on NHS boards; we are just formalising what they do at the moment.

The Convener:

Yes, but there is an issue about how ministers are expressing the policy intention of the bill. They are presenting the change in the volume of public consultation that people can expect as a major step change, yet the financial memorandum seems to suggest that that can be achieved at no additional cost. I wonder whether those two expressions of intent can be reconciled.

Lorna Clark:

The Executive is investing something like an additional £4 million a year, as part of our patient focus and public involvement programme, to help with capacity planning, to ensure that NHS staff are better equipped for the commitments that are required of them, and to ensure that patients and the public are better equipped to be equal partners with the NHS in being consulted and in reacting to consultations. Additional central money is being allocated over and above what NHS boards receive at the moment. That commitment is on-going and is not a direct consequence of the bill. For some time, we have been working on increasing capacity and NHS boards' ability to undertake public involvement. The bill formalises that; it does not do anything particularly new.

The Convener:

The general lesson to draw from that response—which perhaps came out of the earlier questions about the abolition of NHS trusts—is that, to get a better assessment of what is going on, we require more information than we are being given. If the information that we receive focuses narrowly on the specific impact of the legislative process, we will not get the full perspective that we require. If significant resources are already going into public consultation and participation, which the bill formalises, we need to get the whole financial picture of that.

Fergus Ewing:

I want to return to our core function and the prediction that the minister has made, which is supported in paragraph 42 of the financial memorandum, which states:

"There will be no additional expenditure associated with this Bill."

We have heard from the witnesses today that there will be some savings, but they do not know how much those will be, so they cannot say. We have heard that there will be extra costs, but they do not know how much those will be, so they cannot say. On the other hand, page 9 of the explanatory notes makes claims about the dissolution of NHS trusts, CHPs, health boards and powers of intervention, all of which have been either contradicted or seriously questioned in several of the written submissions that we have received.

For example, Highland NHS Board says:

"CHPs may increase costs if central economies of scale are lost."

Argyll and Clyde NHS Board points out that CHPs are significantly more expensive than LHCCs. The witnesses have been unable to say how many CHPs there will be; they do not know. They do not know how many staff there will be. They have said that people are planning for single-system working, but Highland NHS Board says that there may be additional "unfunded" costs in relation to the dissolution of trusts and redundancy costs. I presume that it is not being suggested that any health board has set aside redundancy costs in future budgets, because I would have thought that they could not legally do that.

I wanted to bring all that together and put it to the witnesses that the financial memorandum is the Denis Norden of financial memorandums, in that it is hoped that it will be all right on the night. If that is felt to be too facetious, perhaps they will answer these two questions for me. First, to what percentage are they still confident that paragraph 42 is correct, when it states

"There will be no additional expenditure"?

Secondly, how confident are they—in percentage terms—that there will not be additional expenditure in the first year of operation?

Lorna Clark:

We are confident that no additional costs will be attached to the bill. My colleagues and I have gone through the different sections of the bill and tried to explain how we have come to believe that. A lot of what the bill seeks to do is evolutionary—it builds on things that we are already doing. Boards have been working towards single-system working for some time and have been planning what they need to do.

We are confident that what we have said in the financial memorandum is correct.

So there is no chance that you could be wrong.

Alistair Brown:

It is important that we understand that the financial memorandum expresses the Executive's and ministers' expectation that there will be no additional expenditure; we are not providing an absolute guarantee. Within the world of the NHS, an NHS board could decide to use the occasion of the dissolution of its trusts to do things better locally. It might decide—and it would be quite within its rights to do so—to put more money into some aspect of its administration and less into something else, or it might decide to allocate more of its annual increase to something flowing from the dissolution of trusts.

We are not saying that those will never happen, and there is nothing to prevent NHS boards from taking steps of that kind, but we are saying that we have a confident expectation that no additional expenditure will flow as a direct consequence of this piece of legislation. I believe that that is as far as we can reasonably go. I hope the committee agrees with that.

The Convener:

I think the Finance Committee tends to be sceptical at all times.

I have one final question, on health promotion and the requirements in paragraphs 38, 39 and 40, which describe the statutory duty that will be placed on boards in relation to health improvement. If the statutory function is to be meaningful, how can it be carried out without additional expenditure? In addition, who will audit the boards' provision in meeting that statutory function, because there is a gap in terms of the reorganisation?

Lorna Clark:

Health boards are given an annual allocation and it is up to them to determine within the sums that are available to them how they will manage and deliver local health care systems that meet the health care needs of their local population. A lot of boards have been doing work on health improvement. As with the duty on public involvement, we are building on and making more explicit what a lot of boards have been doing already.

The most recent figures that are available show NHS boards' planned expenditure on health promotion in 2002-03 as around £24 million. That funding is incorporated in the resources that they have and will continue to flow into the present time.

If my colleagues are unable to answer the question about how that expenditure will be monitored, we can find out and get back to you.

That would be helpful. On behalf of the committee, I thank the witnesses for coming along this morning.

Meeting suspended.

On resuming—